Tuesday, November 19, 2024
Home Biotech News Mpox

Mpox

    Featured posts

    GeoVax Receives Massive $300+ Million BARDA Project NextGen Award!

    Mpox Editor / Curator -
    Are we happy, you betcha! We just got back from St Croix where the team from the Beverage Stock...

    Major Mpox Outbreak in the Democratic Republic of Congo.

    Mpox Editor / Curator -
    As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

    Mpox Infections Rise to Almost Double Last Year’s Numbers.

    Mpox Editor / Curator -
    The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...

    China Remains at Risk to Future MonkeyPox Outbreaks.

    Mpox Editor / Curator -
    GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox.

    Latest article

    Nine Page Summary Report on GeoVax (GOVX)

    Mpox Editor / Curator -
    This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

    GeoVax (GOVX) Provides First Half 2024 Business Update.

    Mpox Editor / Curator -
    Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

    Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

    All News Editor / Curator -
    Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.